1. Comparison of the In Vitro and In Vivo Behavior of a Series of NIR-II-Emitting Aza-BODIPYs Containing Different Water-Solubilizing Groups and Their Trastuzumab Antibody Conjugates
   Elisa Chazeau et al, 2024, Journal of Medicinal Chemistry CrossRef
2. Exploring the environmental contamination toxicity and potential carcinogenic pathways of perfluorinated and polyfluoroalkyl substances (PFAS): An integrated network toxicology and molecular docking strategy
   Zhi Lin et al, 2024, Heliyon CrossRef
3. HER2 aberrations in cancer: Implications for therapy
   Min Yan et al, 2014, Cancer Treatment Reviews CrossRef
4. The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo
   Huei Ng et al, 2014, International Journal of Molecular Sciences CrossRef
5. Expression of EGFR family and p53 in a patient with Synchronous Primary Endometrial Adenocarcinoma and Clear Cell Renal Carcinoma: a Case Report
   Priscila Fernanda da Silva Martins et al, 2019, Brazilian Journal of Oncology CrossRef
6. The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions
   Saleh Alrhmoun et al, 2022, Cancers CrossRef
7. Identifying Prognostic Biomarkers Related to m6A Modification and Immune Infiltration in Renal Cell Carcinoma
   Junjie Ye et al, 2022, Genes CrossRef
8. Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas
   Erica Quaquarini et al, 2024, Cancers CrossRef
9. 99mTc-Radiolabeled Silica Nanocarriers for Targeted Detection and Treatment of HER2-Positive Breast Cancer
   Paolo Rainone et al, 2021, International Journal of Nanomedicine CrossRef